GTx, Inc. (NASDAQ:GTXI)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $16.19 and last traded at $15.55, with a volume of 76200 shares trading hands. The stock had previously closed at $15.55.
A number of equities research analysts have recently weighed in on the company. Stifel Nicolaus assumed coverage on GTX in a research report on Thursday, November 9th. They set a “buy” rating for the company. BidaskClub downgraded GTX from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. ValuEngine upgraded GTX from a “sell” rating to a “hold” rating in a research report on Wednesday, February 7th. Zacks Investment Research upgraded GTX from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Finally, Robert W. Baird assumed coverage on GTX in a research report on Tuesday, November 21st. They set an “outperform” rating and a $17.00 target price for the company. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $17.00.
The company has a market capitalization of $334.98, a PE ratio of -8.84 and a beta of 1.78.
In related news, CEO Marc Steven Hanover sold 7,309 shares of GTX stock in a transaction on Friday, January 5th. The stock was sold at an average price of $11.33, for a total transaction of $82,810.97. Following the completion of the sale, the chief executive officer now directly owns 129,990 shares of the company’s stock, valued at $1,472,786.70. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Henry Patton Doggrell sold 4,965 shares of GTX stock in a transaction on Friday, January 5th. The stock was sold at an average price of $11.33, for a total value of $56,253.45. Following the sale, the vice president now directly owns 54,804 shares of the company’s stock, valued at $620,929.32. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,364 shares of company stock valued at $174,074. 41.20% of the stock is currently owned by corporate insiders.
Several institutional investors have recently made changes to their positions in the stock. Abingworth LLP acquired a new stake in shares of GTX during the third quarter worth $2,781,000. Caxton Corp acquired a new stake in shares of GTX during the third quarter worth $531,000. Millennium Management LLC acquired a new stake in shares of GTX during the fourth quarter worth $749,000. EAM Investors LLC acquired a new stake in shares of GTX during the fourth quarter worth $551,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of GTX during the second quarter worth $124,000. 11.96% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: “GTX (GTXI) Sets New 12-Month High at $16.19” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/20/gtx-gtxi-sets-new-12-month-high-at-16-19.html.
GTX Company Profile
GTx, Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs).
Receive News & Ratings for GTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTX and related companies with MarketBeat.com's FREE daily email newsletter.